Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy.

Cavaletti G, Bogliun G, Marzorati L, Zincone A, Piatti M, Colombo N, Franchi D, La Presa MT, Lissoni A, Buda A, Fei F, Cundari S, Zanna C.

Ann Oncol. 2004 Sep;15(9):1439-42.

PMID:
15319252
2.

A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study.

Lissoni AA, Colombo N, Pellegrino A, Parma G, Zola P, Katsaros D, Chiari S, Buda A, Landoni F, Peiretti M, Dell'anna T, Fruscio R, Signorelli M, Grassi R, Floriani I, Fossati R, Torri V, Rulli E.

Ann Oncol. 2009 Apr;20(4):660-5. doi: 10.1093/annonc/mdn690. Epub 2009 Jan 30.

PMID:
19181826
3.

Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale.

Cavaletti G, Bogliun G, Marzorati L, Zincone A, Piatti M, Colombo N, Parma G, Lissoni A, Fei F, Cundari S, Zanna C.

Neurology. 2003 Nov 11;61(9):1297-300.

PMID:
14610145
4.

Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting?

Moioli M, Papadia A, Mammoliti S, Pacella E, Menoni S, Menada MV, Ragni N.

Minerva Ginecol. 2012 Apr;64(2):95-107. English, Italian.

PMID:
22481620
5.
6.

Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.

Belli L, LeChevalier T, Gottfried M, Adams D, Ruffie P, LeCesne A, Tete L, Pellae-Cosset B.

Semin Oncol. 1995 Dec;22(6 Suppl 15):29-33.

PMID:
8643967
7.

Peripheral neuropathy induced by administration of cisplatin- and paclitaxel-based chemotherapy. Could it be predicted?

Argyriou AA, Polychronopoulos P, Koutras A, Iconomou G, Iconomou A, Kalofonos HP, Chroni E.

Support Care Cancer. 2005 Aug;13(8):647-51. Epub 2005 Feb 15.

PMID:
15711945
8.
9.
10.

Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy.

Berger T, Malayeri R, Doppelbauer A, Krajnik G, Huber H, Auff E, Pirker R.

Eur J Cancer. 1997 Aug;33(9):1393-9.

PMID:
9337680
11.

Clinical and genetic predictors of paclitaxel neurotoxicity based on patient- versus clinician-reported incidence and severity of neurotoxicity in the ICON7 trial.

Park SB, Kwok JB, Asher R, Lee CK, Beale P, Selle F, Friedlander M.

Ann Oncol. 2017 Nov 1;28(11):2733-2740. doi: 10.1093/annonc/mdx491.

PMID:
29117336
12.

Clinical phase I study of paclitaxel followed by cisplatin in advanced head and neck squamous cell carcinoma.

Hanauske AR, Schilling T, Heinrich B, Kau R, Herzog M, Quasthoff S, Bochtler H, Diergarten K, Rastetter J.

Semin Oncol. 1995 Dec;22(6 Suppl 14):35-9.

PMID:
8553082
13.
14.

Maximum tolerated dose and early response - results of a phase I trial of paclitaxel and cisplatin with radiation therapy in carcinoma of the cervix.

Prasad E, Viswanathan PN, Rangad VF, Pavamani S, Ram TS.

Clin Oncol (R Coll Radiol). 2009 Aug;21(6):488-93. doi: 10.1016/j.clon.2009.03.002. Epub 2009 Apr 21.

PMID:
19386478
15.

Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian Cancer.

Cervantes A, Mendiola C, del Campo JM, Massuti B, Casado A, Escobedo A, Moyano A, Ojeda B, Poveda A, Benito D.

Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-40-S15-43.

PMID:
9346221
16.

Seizure following chemotherapy (paclitaxel and cisplatin) in a patient of carcinoma cervix.

Dana R, Spartacus RK, Mutha S, Bhat P.

Indian J Pharmacol. 2016 Nov-Dec;48(6):736-738. doi: 10.4103/0253-7613.194863.

17.

Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.

Gibson MK, Li Y, Murphy B, Hussain MH, DeConti RC, Ensley J, Forastiere AA; Eastern Cooperative Oncology Group.

J Clin Oncol. 2005 May 20;23(15):3562-7.

PMID:
15908667
18.

External beam radiotherapy and high-dose brachytherapy combined with cisplatin and paclitaxel in patients with advanced cervical carcinoma.

Petera J, Odrázka K, Frgala T, Spacek J.

Gynecol Oncol. 2005 Nov;99(2):334-8. Epub 2005 Jul 14.

PMID:
16023181
19.
20.

Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study.

Moore DH, Blessing JA, McQuellon RP, Thaler HT, Cella D, Benda J, Miller DS, Olt G, King S, Boggess JF, Rocereto TF.

J Clin Oncol. 2004 Aug 1;22(15):3113-9.

PMID:
15284262

Supplemental Content

Support Center